Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the intergroup rhabdomyosarcoma study group

Journal of Clinical Oncology

Volumn 17, Issue 11, 1999, Pages 3487-3493

  Pappo, Alberto S ^a   Anderson, James R ^a   Crist, William M ^a   Wharam, Moody D ^a   Breitfeld, Phillip P ^a   Hawkins, Douglas ^a   Raney, R Beverly ^a   Womer, Richard B ^a   Parham, David M ^a   Qualman, Steven J ^a   Grier, Holcombe E ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; VINCRISTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHABDOMYOSARCOMA; RISK FACTOR; SURVIVAL RATE;

EID: 0032722352     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.11.3487     Document Type: Article

References (20)

1. Crist W, Gehan EA, Ragab AH, et al: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630, 1995
2. Pappo AS, Shapiro DN, Crist WM, et al: Biology and therapy of pediatric rhabdomyosarcoma. J Clin Oncol 13:2123-2139, 1995
3. Raney BR, Crist WM, Maurer HM, et al: Prognosis of children with soft tissue sarcoma who relapse after achieving a complete response: A report from the Intergroup Rhabdomyosarcoma Study I. Cancer 52:44-50, 1983
4. Klingebiel T, Pertl U, Hess C, et al: Treatment of children with relapsed soft tissue sarcoma: Report of the German CESS/CWS REZ 91 trial. Med Pediatr Oncol 30:269-275, 1998
5. Crist WM, Garnsey L, Beltangady MS, et al: Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II. J Clin Oncol 8:443-452, 1990
6. Rodary C, Gehan E, Flamant F, et al: Prognostic factors in 951 nonmetastatic rhabdomyosarcoma in children: A report from the International Rhabdomyosarcoma Workshop. Med Pediatr Oncol 19:89-95, 1991
7. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
8. Peto R, Pike M, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient: I - Analysis and examples. Br J Cancer 35:1-39, 1977
9. O'Bryan RM, Luce JK, Talley RW, et al: Phase II evaluation of adriamycin in human neoplasia. Cancer 32:1-6, 1973
10. Pappo AS, Etcubanas E, Santana VM, et al: A phase II trial of ifosfamide in previously untreated children and adolescents with unresectable rhabdomyosarcoma. Cancer 71:2119-2125, 1993
11. Pratt CB, Douglass EC, Etcubanas EL, et al: Ifosfamide in pediatric malignant solid tumors. Cancer Chemother Pharmacol 24:24-27, 1989
12. Kung F, Pratt C, Vega R, et al: Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. Cancer 71:1898-1903, 1993
13. Blaney S, Berg S, Pratt C, et al: A phase I study of irinotecan in pediatric patients: A Pediatric Oncology Group study. Proc Am Soc Clin Oncol 18:195a, 1998 (abstr 750)
14. Vietti T, Crist W, Ruby E, et al: Topotecan window in patients with rhabdomyosarcoma (RMS): An IRSG study. Proc Am Soc Clin Oncol 16:510a, 1997 (abstr 1837)
15. Houghton P, Chesire PJ, Hallman J, et al: Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low doses in protracted schedules to mice bearing xenografts of human tumors. Cancer Chemother Pharmacol 36:393-403, 1995
16. Stewart C, Zamboni W, Crom W, et al: Topoisomerase I interactive drugs in children with cancer. Inv New Drugs 14:37-47, 1996
17. Houghton PJ, Shapiro DN, Houghton JA: Rhabdomyosarcoma: From the laboratory to the clinic. Pediatr Clin North Am 38:349-364, 1991
18. Furman W, Stewart C, Pratt C, et al: A phase I study of irinotecan (CPT-11) in children with relapsed solid tumors. Proc Am Soc Clin Oncol 17:187a, 1998 (abstr 721)
19. Flamant F, Rodary C, Rey A, et al: Treatment of non-metastatic rhabdomyosarcoma in childhood and adolescence: Results of the second study of the International Society of Pediatric Oncology -MMT84. Eur J Cancer 34:1050-1062, 1998
20. Rousseau P, Flamant F, Quintana E, et al: Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: Results of the International Society of Pediatric Oncology MMT 84 study. J Clin Oncol 12:516-521, 1994